Please assess the completion status of the following clinical trial:

Trial Title: Study of Pain Control in Hemorrhoidectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \> 18 years of age at the Screening visit~* American Society of Anesthesiologists (ASA) class 1-3~* Scheduled to have a two or three column excisional hemorrhoidectomy under general anesthesia using the Milligan-Morgan technique~* For female subjects, surgically sterile or at least two years menopausal, or using an acceptable method of birth control; must have a documented negative blood or urine pregnancy test within 24 hours before surgery~* Clinical lab values less than or equal to twice the upper limit of normal or, if abnormal, deemed not clinically significant per the Investigator.~* Ability to understand the requirements of the study, provide written informed consent, abide by the study restrictions, and agree to return for the required assessments~* Able to speak, read, and understand the language of all subject-facing documents, including the ICF and study questionnaires~* Able and willing to comply with all study visits and procedures~Exclusion Criteria:~* Single-column hemorrhoidectomy or hemorrhoidectomy without an internal component~* Body weight less than 50 kilograms (110 pounds)~* History of hypersensitivity or idiosyncratic reactions or amide-type local anesthetics, opioids, or propofol~* Current painful physical condition or concurrent surgery other than hemorrhoids that may require analgesic treatment (such as non-steroidal anti-inflammatory drug \[NSAID\], opioid, selective serotonin reuptake inhibitor \[SSRI\], tricyclic antidepressant, gabapentin, pregabalin) in the postoperative period for pain that is not strictly related to the hemorrhoidectomy procedure and may confound the postoperative assessments~* Concurrent fissurectomy~* Use of any NSAID including selective COX-2 inhibitor, opioid, SSRI, tricyclic antidepressant, gabapentin, or pregabalin within three days of surgery~* Use of acetaminophen within 24 hours of surgery~* Chronic users of analgesic medications, including taking opioid medications for more than 14 days in the last 3 months, or non-opioid pain medications more than 5 times per week~* History of, suspected, or known addiction to or abuse of drugs or alcohol within the past two years~* Current use of glucocorticosteroids or use of glucocorticoids within one month of enrollment into this study~* HIV infection or hepatitis~* Currently pregnant, nursing, or planning to become pregnant during the course of the study or within one month of study drug administration~* Any psychiatric, psychological, medical, or laboratory condition that the investigator feels makes the subject an inappropriate candidate for this clinical trial~* Subjects who have received another investigational drug within the longer of the last 30 days or 10 elimination half-lives~* Previous participation in a SKY0402 study~* Failure to pass drug and alcohol screen

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- SKY0402 (Type: EXPERIMENTAL): During the hemorrhoidectomy, 30cc of SKY0402 is injected into the wound.
- Placebo (Type: PLACEBO_COMPARATOR): During the hemorrhoidectomy, 30cc Placebo injected into the wound.

Based on this trial design, predict the completion outcome and termination type (if applicable).